Neovasc (NVCN) Stock Price, News & Analysis

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 399 shs
• Average Volume: 2,123 shs
• Market Capitalization: C$110.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVCN Stock Analysis - Frequently Asked Questions

How do I buy shares of Neovasc?

Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Bionano Genomics (BNGO) and Meta Platforms (META).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Manufacturing
• Industry: Surgical & Medical Instrument Manufacturing
• Sub-Industry: Medical Equipment
• Current Symbol: TSE:NVCN
• CIK: N/A
• Web: www.neovasc.com
• Phone: 16042704344
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($20.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-33,520,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -78.25%
• Return on Assets: -32.95%

Debt

• Debt-to-Equity Ratio: 44.86
• Current Ratio: 8.44
• Quick Ratio: 8.04

Sales & Book Value

• Annual Sales: C$3.11 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.05
• Book Value: C$10.22 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,760,000
• Free Float: N/A
• Market Cap: C$110.81 million
• Optionable: Not Optionable
• Beta: 2.01